Search
Pelthos Therapeutics Ord Shs
PTHSAdd to Watchlist
23.690USD
+0.170+0.72%
Market hours 09/24, 09:31（ET）
82.44MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.72%
5 Days
+21.99%
1 Month
-7.13%
6 Months
+7.68%
Year to Date
-23.58%
1 Year
-30.24%
Key Figures
23.380Open
24.300High
1.16KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
23.520Prev. Close
23.140Low
27.21KTurnover
LossP/E Static
-54.92P/B
0.00%Div Yield TTM
-70.53%ROA
37.50052wk High
14.19Volume Ratio
-7.96MNet Profit
3.48MShares
-22.9164EPS TTM
--Beta
-333.85%ROE
18.19052wk Low
4.93%Amplitude
72.25%Gross Margin
82.44MMarket Cap
0.18Reward/Risk
4.98%Risk Rate
Analyst Rating
Pelthos Therapeutics Ord Shs Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral
Pelthos Therapeutics Ord Shs Latest Earnings Call Transcripts
Pelthos Therapeutics (PTHS) Q2 2026 Earnings Call: Revenue Rises 45%
Pelthos Therapeutics’ Q2 2026 earnings call covers $15.4 million in net product revenue, 48% prescription growth and planned 2027 product launches.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-6.62/-3.05
Revenue / Forecast
15.60M/15.27M
Ownership
| Shareholders | Proportion |
|---|---|
| Ligand Pharmaceuticals Inc | 44.70% |
| Murchinson Ltd. | 8.34% |
| Ikarian Capital LLC | 7.62% |
| 3I Management LLC | 6.36% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 48.34% |
| Investment Advisor/Hedge Fund | 17.52% |
| Hedge Fund | 11.77% |
| Individual Investor | 7.78% |
Related Instruments
+3.60%
+0.52%
-0.23%
+0.64%
+0.53%
+0.82%
-0.14%
-0.30%
+0.20%
+1.19%
+1.07%
-0.52%
+0.25%
-0.08%
-1.56%
-0.85%
+1.86%
+0.39%
-1.41%
+1.16%Popular Instruments
51184.400
-305.600 (-0.59%)
30258.200
-219.700 (-0.72%)
7670.800
-36.200 (-0.47%)
14250.000
-172.000 (-1.19%)
65468.000
-661.000 (-1.00%)
6280.200
-9.800 (-0.16%)
96.093
+3.603 (+3.90%)
336.410
-0.610 (-0.18%)
222.465
-3.045 (-1.35%)
4256.650
-29.590 (-0.69%)
FAQs
What is the current price of Pelthos Therapeutics Ord Shs (PTHS)?
The current price of Pelthos Therapeutics Ord Shs (PTHS) is 23.52.
What is the symbol of Pelthos Therapeutics Ord Shs?
The ticker symbol of Pelthos Therapeutics Ord Shs is PTHS.
What is the 52-week high of Pelthos Therapeutics Ord Shs?
The 52-week high of Pelthos Therapeutics Ord Shs is 37.50.
What is the 52-week low of Pelthos Therapeutics Ord Shs?
The 52-week low of Pelthos Therapeutics Ord Shs is 18.19.
What is the market capitalization of Pelthos Therapeutics Ord Shs?
The market capitalization of Pelthos Therapeutics Ord Shs is 81.85M.
Is Pelthos Therapeutics Ord Shs (PTHS) currently rated as Buy, Hold, or Sell?
According to analysts, Pelthos Therapeutics Ord Shs (PTHS) has an overall rating of Buy, with a price target of 53.14.
What is the Earnings Per Share (EPS TTM) of Pelthos Therapeutics Ord Shs (PTHS)?
The Earnings Per Share (EPS TTM) of Pelthos Therapeutics Ord Shs (PTHS) is -22.92.